Quantum-Si incorporated (NASDAQ:QSI) CEO Jeffrey Alan Hawkins Sells 23,707 Shares of Stock

Quantum-Si incorporated (NASDAQ:QSI) CEO Jeffrey Alan Hawkins sold 23,707 shares of the firm’s stock in a transaction that occurred on Friday, March 21st. The stock was sold at an average price of $1.39, for a total value of $32,952.73. Following the transaction, the chief executive officer now owns 2,646,716 shares in the company, valued at $3,678,935.24. This represents a 0.89 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Quantum-Si Price Performance

NASDAQ:QSI opened at $1.48 on Tuesday. The firm has a market cap of $271.05 million, a price-to-earnings ratio of -2.31 and a beta of 2.75. The firm’s fifty day moving average price is $1.78 and its 200 day moving average price is $1.49. Quantum-Si incorporated has a 1-year low of $0.61 and a 1-year high of $5.77.

Institutional Investors Weigh In On Quantum-Si

A number of hedge funds have recently added to or reduced their stakes in the company. Renaissance Technologies LLC raised its stake in shares of Quantum-Si by 1,211.4% during the 4th quarter. Renaissance Technologies LLC now owns 544,956 shares of the company’s stock worth $1,471,000 after buying an additional 503,400 shares in the last quarter. XTX Topco Ltd grew its holdings in Quantum-Si by 460.5% during the fourth quarter. XTX Topco Ltd now owns 245,585 shares of the company’s stock worth $663,000 after acquiring an additional 201,773 shares during the period. Two Sigma Investments LP purchased a new position in Quantum-Si in the fourth quarter worth $412,000. Geode Capital Management LLC lifted its holdings in Quantum-Si by 6.7% in the third quarter. Geode Capital Management LLC now owns 2,316,921 shares of the company’s stock valued at $2,044,000 after acquiring an additional 145,091 shares during the period. Finally, Centiva Capital LP purchased a new stake in shares of Quantum-Si during the 4th quarter worth $387,000. Institutional investors and hedge funds own 39.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the stock. Alliance Global Partners restated a “buy” rating on shares of Quantum-Si in a research report on Wednesday, March 5th. National Bankshares set a $3.65 target price on shares of Quantum-Si in a report on Wednesday, March 5th. Finally, HC Wainwright reissued a “buy” rating and set a $5.50 price target on shares of Quantum-Si in a report on Tuesday, January 14th.

Quantum-Si Company Profile

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.